Literature DB >> 8323911

The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease.

W R Nunery1, R T Martin, G W Heinz, T J Gavin.   

Abstract

We retrospectively reviewed the smoking habits of 124 patients with Graves' ophthalmopathy. We divided these patients into those without restrictive myopathy (type I) and those with restrictive myopathy (type II). Sixty-three percent of type I and 83% of type II patients were smokers at the time of diagnosis. The incidence of smoking in an age- and gender-matched randomly selected control population in the same geographic area was 30% for controls matched to our type I group and 26.6% for controls matched to our type II group. We believe smoking is an important factor in the development of both clinical subtypes of Graves' ophthalmopathy.

Entities:  

Mesh:

Year:  1993        PMID: 8323911     DOI: 10.1097/00002341-199306000-00001

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  20 in total

1.  Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy.

Authors:  B M Hosal; J K Swanson; C R Thompson; S Kubota; K Gunji; J S Kennerdell; J R Wall
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

Review 2.  Relationship between cigarette smoking and Graves' ophthalmopathy.

Authors:  L Hegediüs; T H Brix; P Vestergaard
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

3.  Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Authors:  Don O Kikkawa
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

Review 4.  Thyroid eye disease.

Authors:  D H Char
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

5.  Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.

Authors:  Jun Soo Byun; Nam Ju Moon; Jeong Kyu Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-12       Impact factor: 3.117

6.  Imaging biomarkers in thyroid eye disease and their clinical associations.

Authors:  Shikha Chaganti; Katrina Nelson; Kevin Mundy; Robert Harrigan; Robert Galloway; Louise A Mawn; Bennett Landman
Journal:  J Med Imaging (Bellingham)       Date:  2018-10-16

7.  Preoperative clinical features of reactivated of Graves' orbitopathy after orbital decompression.

Authors:  Y J Woo; J W Kim; J S Yoon
Journal:  Eye (Lond)       Date:  2017-01-06       Impact factor: 3.775

Review 8.  Differential involvement of orbital fat and extraocular muscles in graves' ophthalmopathy.

Authors:  Wilmar M Wiersinga; Noortje I Regensburg; Maarten P Mourits
Journal:  Eur Thyroid J       Date:  2013-02-26

9.  Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features.

Authors:  Onur Konuk; Zafer Onaran; Suna Ozhan Oktar; Cem Yucel; Mehmet Unal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-16       Impact factor: 3.117

10.  Update on the medical treatment of Graves' ophthalmopathy.

Authors:  Gregory J Griepentrog; James A Garrity
Journal:  Int J Gen Med       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.